Merck & Co. 8-K

Debt financing

Closed a public note offering spanning 2028–2056 maturities, adding fixed- and floating-rate debt.

Filed 2026-05-22 16:21 ET

Summary

Merck closed a $6.0B underwritten public offering of notes due 2028–2056, adding debt across floating-rate and fixed-rate tranches.

Key Figures

  • $6.0B aggregate principal: $0.5B floating-rate notes due 2028; $1.0B at 4.300% due 2028; $0.5B at 4.650% due 2031; $1.0B at 4.950% due 2033; $1.5B at 5.200% due 2036; $0.5B at 5.750% due 2046; and $1.0B at 5.850% due 2056. The floating-rate notes’ rate was not specified.

Investor Takeaways

  • The notes’ scheduled maturities and fixed coupons span 2028–2056; the floating-rate tranche is due in 2028.

The summary is written by an AI model reading the filing.

Model 005 · prompt 01d34d48e3

Feedback